Our company
+
Activities
+
Sustainability
+
Knowledge center
Products
en
fr
About us
Seqens group
Governance
Scientific committee
Locations
Our Partners
Compliance
R&D
Key expertises
Excellence centers
Innovation Hub
Careers
Join the Seqens adventure
Our Commitment to Youth
Our jobs and our teams
Activities
Pharmaceuticals
Custom & specialties
Personal Care
Cell&Gene
Biotechnologies
News
Our news
Activities
Pharmaceuticals
Custom & Specialties
Personal Care
Cell&gene
Biotechnologies
Sustainability
CSR strategy
Environment
Social
Ethics
Sustainable portfolio
CSR Library
Show menu
News
All news
CSR
Events
General
PERSONAL CARE
Press release
Products & Technologies
Protéus
08/03/2022
General
Meeting with Yael Gofni for the International Women’s Day
Read more
25/01/2022
General
Update on isopropanol plant expansion
Read more
17/12/2021
General
SK Capital becomes the new majority shareholder of Seqens – Q&A
Read more
16/12/2021
General
Seqens becomes a partner of the RoLA-FLEX project
Read more
24/11/2021
General
Seqens Prize of the French Académie des Sciences 2021
Read more
07/09/2021
SEQENS unveils its new pharmaceutical quality control laboratory in the presence of Jean Castex, French Prime Minister.
Read more
05/07/2021
General
Labcom HitCat Inauguration in partnership with the CNRS
Read more
20/05/2021
General
Seqens is proud to announce the official partnership between Alganelle and Sederma for the development of a future cosmetic ingredient.
Read more
17/05/2021
General
Biocatalysis: a science in permanent technological evolution
Read more
10/05/2021
General
Essential molecules’ production in France: our investment plan
Read more
10/05/2021
General
Seqens’ commitment to reducing its carbon footprint
Read more
27/04/2021
General
Nitrosamines: quick mobilization of a multidisciplinary team in response to regulatory changes
Read more
1
2
3
4
+
Seqens will be at CPHI
Book a meeting